Negative interference by jaundiced plasma in kinetic Jaffe methods for plasma creatinine determination is caused by both conjugated and unconjugated bilirubin. The amount of interference observed is method-and temperaturedependent and is directly related to bilirubin concentration but is independent of the creatinine concentration. Bilirubin also significantly reduces the precision of the creatinine estimation. A mechanism of bilirubin interference in kinetic Jaffe methods is proposed and the influence of picrate concentration, hydroxide concentration and temperature on the magnitude of bilirubin interference has been investigated.
During the last 15 years, there has been considerable interest in the use of kinetic Jaffe methods for the determination of plasma creatinine. 1-3 Kinetic Jaffe methods have been shown to have several advantages over endpoint Jaffe methods for plasma creatinine determination, including speed of analysis and lack of interference by serum proteins so that a precipitation or dialysis step is unnecessary.f Kinetic Jaffe methods are therefore suitable for use with discrete analysers, especially centrifugal analysers where there is no prior removal of protein from the sample before analysis. ' Furthermore, it has been shown that by adjusting the time interval over which the Jaffe reaction is monitored, it is possible to minimise interference in the reaction by substances such as glucose, ketones and organic acids.:' A comprehensive review on the estimation of creatinine has been published recently. 4 Since the widespread introduction of kinetic Jaffe methods for creatinine determination, many authors have reported negative interference when jaundiced samples are analysed by these methods.v ? However, there is considerable disagreement as to the nature and magnitude of this interference. For example, it has been claimed that negative interference is linearly related to bilirubin concentration,"
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whereas others have shown no such correlation. s, 11, 14, Ih It has also been claimed that bilirubin is not the main cause of the interference at all, but that other compounds present in jaundiced samples are responsible, for example, biliverdin. II, 13 Among those authors who have implicated bilirubin there is only scant information on the mechanism of interferences, 7, 9 and very few data on whether conjugated bilirubin as well as unconjugated bilirubin interferes. Also, the dependence of the observed interference on creatinine concentration and on the concentration of picrate and hydroxide in the reagent has not been studied.
The present study was undertaken to attempt to clarify discrepancies in the data obtained by earlier workers.
Materials and methods
All reagents were analytical grade.
SAMPLE PREPARATION
Plasma samples were obtained from laboratory staff and hospital patients. Samples were either analysed immediately or stored in the dark at -70°C until required. Unconjugated bilirubin and biliverdin (Sigma Chemical Company, Poole, Dorset, UK) were dissolved in dimethyl sulphoxide (DMSO) and added to normal human plasma (NHP) to give the appropriate concentration as described by Billing, Haslam and Wald. l7 Human bile obtained at cholecystectomy was used as a source of conjugated bilirubin. Determination of the conjugated and unconjugated bilirubin in the bile sample showed that more than 90% of the bilirubin was conjugated. The bile was added to NHP to give the appropriate concentration of conjugated bilirubin.
Sodium salts of bile acids and bile acid conjugates (Sigma Chemical Co.) were first dissolved in 0·15 M NaCI and then added to NHP to give final concentrations of 25 and 200 !J.moUL respectively. Cholate, deoxycholate and chenodeoxycholate together with their glycine and taurine conjugates were studied.
A sample of NHP containing 200 !J.moUL ammonia was prepared by adding" 0·2 mL of a 10 mrnol/L stock solution of ammonium sulphate to 10 mL of plasma.
For the recovery experiments, a 10 mmol/L stock solution of creatinine in 0·1 M HCI was added to various samples to give final increments in plasma creatinine concentration of 100 and 300 umol/L, Immediately after addition of the creatinine solution an equivalent volume of 0·1 M NaOH was added to maintain the sample at neutral pH.
There was negligible dilution of the creatinine in the NHP pool by the addition of solutions containing the various substances of interest. Any dilution was taken into account by the addition of an equivalent volume of 0·15 M NaC~to the same NHP pool for use as a control.
Investigations were carried out into the effect of light treatment on the apparent plasma creatinine concentration of five icteric samples with bilirubin concentrations of 210 to 450 !J.moUL. The samples contained in glass screw cap bottles were illuminated for 72 h under a 100 watt tungsten filament lamp. Chemical estimation of the bilirubin concentration in the samples before and after illumination confirmed that more than 85% of the bilirubin had been destroyed by this procedure. The samples were then analysed in triplicate by the creatinine methods described below.
BILIRUBIN ESTIMATION
Plasma bilirubin was estimated manually by the method of Malloy and Evelyn.!" CREATININE ESTIMATION Samples were analysed by four alkaline picrate methods. Technicon 'Set point'® calibrator Lot V5A 118 was used as calibrant throughout. Reagents were filtered through Whatman No.1 filter paper before use as necessary.
Continuous flow method
Analyses using a continuous flow 'end point' Jaffe method were carried out on the Technicon SMA2 using the recommended Technicon procedure (Technicon Ltd, Basingstoke, UK). After dialysis, the sample stream was made alkaline by the addition of 0·5 M sodium hydroxide. A saturated solution of picric acid was then added to the analytical stream and mixed. After 3·5 min at room temperature the ASlJ5nm was measured and was linearly related to creatinine concentration. Final concentrations of picrate and hydroxide in the reaction mixture were 10 and 90 mmollL respectively.
Kinetic Jaffe methods
(i) Beckman creatinine analyser (Beckman Instruments, Galway, Ireland). Analyses were performed on the Beckman creatinine analyser using recommended Beckman Jaffe reagents. The Beckman hydroxide reagent contains borate/phosphate and a surfactant to reduce interference from glucose and proteins respectively. 19. 2lJ Sample (25 !J.L) was mixed with 1·0 mL of alkaline picrate reagent preheated to 37°C within the analyser reaction chamber. The rate of change of AS2lJnm was determined at 25·6 s after addition of sample to reagent and was directly proportional to the creatinine concentration. Final concentrations of picrate and hydroxide in the reaction mixture were 10 and 146 rnmol/L respectively.
(ii) J T Baker kinetic method (J T Baker Chemicals, Deventer, Holland). The J T Baker hydroxide reagent incorporates a ferricyanide pre-oxidation step to oxidise bilirubin to biliverdin before the picrate is added in order to reduce bilirubin interference.?' Borate/ phosphate and sodium dodecyl sulphate (SDS) are included to reduce interference from glucose and proteins. The analyses were performed manually using a Perkin-Elmer AS UVIVIS spectrophotometer (Perkin-Elmer, Beaconsfield, Bucks, UK). Sample (0·15 mL) was added to 1·0 mL of hydroxide reagent containing ferricyanide. After incubation at 37°C for 5 min, 0·5 mL of pre-warmed picrate reagent was added and the change in A51Mnm between 30 and 90 s after addition of the picrate was noted and was directly proportional to creatmme concentration. Final concentrations of ferricyanide, SDS, picrate and hydroxide in the reaction mixture were 15 f.lM, 24 mM, 14 mM and 180 mM respectively.
(iii) Centrifichem kinetic method (Baker Instruments Ltd, Egham, Surrey, UK). Kinetic creatinine analyses were performed on the Centrifichem 600 analyser using the recommended Centrifichem method and reagents. Final concentrations of picrate and hydroxide in the reaction mixture were 13 and 136 mmolJL respectively. The reagent did not contain any additional components. Sample (4lJ ul.) and diluent (55 ul, H 2 0 ) were mixed with 350 ul, of alkaline picrate reagent in the analyser rotor at a temperature of 30°C. The analyser measured the change in A5211nl11 occurring between 15 and 75 s after mixing and this change was directly proportional to the concentration of creatinine in the sample.
(iv) Additional kinetic analyses. For the experiments performed to determine whether reagents gave different results on different instruments, Beckman reagents were used on the Centrifichem analyser and Centrifichem reagents were used on the Beckman analyser. When Beckman reagents were used on the Centrifichem, 9 ul, of sample and 30 ul, of diluent (H 2 0 ) were mixed with 350 ul. of Beckman alkaline picrate reagent in the analyser rotor at a temperature of 37°C. The concentration of creatinine in the sample was determined from the change in A5211nm occurring between 15 and 45 s after mixing. When Centrifichem reagents were used on the Beckman, the volumes of sample and reagent were the same as those described in section (i) above.
(v) Studies on the mechanism of bilirubin interference. In these studies, raw absorbance data was obtained at 520 and 620 nm for each of the three kinetic Jaffe reagents using the Centrifichem in 'rate' mode. The relative proportions of sample and reagent used were those given in sections (i), (ii) and (iii) above. The influence of hydroxide concentration, picrate concentration and temperature on the reaction of bilirubin with hydroxide and on the magnitude of bilirubin interference was also studied on the Centrifichem. Although the concentrations of hydroxide and picrate were varied, the volumes of sample and reagent used were always those described in section (iii) above.
STATISTICAL ANALYSES
Where appropriate, data were analysed using the Mann-Whitney U test and by least squares Table 1 shows the effect of added bilirubin, biliverdin, bile acids and ammonia on the apparent creatinine concentration of pooled normal human plasma. The final concentrations of the various compounds added were equal to or in excess of those found in jaundiced plasma. None of the added substances interfered significantly with the results of the creatinine determinations carried out on the SMA2 using the recommended Technicon procedure. When Beckman reagents were used either on the Beckman analyser or on the Centrifichem, bilirubin produced only slight negative interference. In contrast, there was marked negative interference by bilirubin when Centrifichem or J T Baker reagents were used. Biliverdin, bile acids and ammonia did not show interference by any of the methods. Figure 1 shows the relationship between unconjugated bilirubin concentration and the apparent creatinine concentration for two human plasma pools, one containing approximately 80 umol/L creatinine and the other approximately 400 urnol/L creatinine.
The addition of unconjugated bilirubin to the plasma pools had no effect on the apparent creatinine concentration when the samples were analysed on the SMA 2 ( Fig. la) . When the samples were analysed on the Beckman creatinine analyser using Beckman reagents, a small decrease in the apparent creatinine concentration was noted as increasing amounts of unconjugated bilirubin were added to the serum pools ( Fig. lb) . When the samples were analysed on the Centrifichem analyser using Centrifichem reagents ( Fig. lc) or manually using the J T Baker kit ( Fig. l d) , results were obtained which were consistent with a linear relationship between the unconjugated bilirubin concentration and the amount of interference observed. Addition of unconjugated bilirubin to the serum pools also adversely affected the precision of the creatinine analyses. This is clearly evident from the increase in size of the bars representing the SDs of the replicate analyses in samples containing added unconjugated bilirubin. Furthermore, the slopes of the regression lines obtained using the low and high creatinine pools are almost identical and therefore the interference by unconjugated bilirubin is independent of the concentration of creatinine in the sample.
The same linear relationship between Negative interference by jaundiced plasma 89 bilirubin concentration and apparent creatinine concentration was also obtained when conjugated bilirubin was added to the two plasma pools. The observed interference was again independent of creatinine concentration and the precision of the creatinine estimation was likewise adversely affected .
RECOVERY EXPERIMENTS
The recovery of added creatinine to grossly hyperbilirubinaemic plasma was investigated and ranged between 96 and 106% for all four alkaline picrate reagents even when the concentration of bilirubin in the samples exceeded 350 urnol/L,
EFFECT OF LIGHT TREATMENT ON THE
APPARENT PLASMA CREATININE
CONCENTRATION OF ICTERIC SAMPLES
There was little difference in apparent plasma creatinine concentration of the icteric samples following light treatment when the samples were analysed on the Technicon SMA2 or Beckman analyser using Beckman reagents.
When the samples were analysed on the Centrifichem analyser with Centrifichem reagents or manually using the J T Baker kinetic method, a very large increase in apparent creatinine concentration occurred following light treatment irrespective of whether the bilirubin was conjugated or unconjugated. Plasma samples obtained from hospital inpatients with a wide range of bilirubin concentration were analysed for creatinine in duplicate on the SMA2, on the Beckman creatinine analyser using Beckman reagents and on the Centrifichem using Centrifichem reagents. When the differences between SMA2 and Beckman creatinine results were plotted against total bilirubin concentration, little discrepancy between the results obtained by the two methods was observed, even when the samples contained high concentrations of bilirubin ( Fig.  2a) . In contrast, when the differences between the SMA2 and Centrifichem creatinine results were plotted against total bilirubin concentration ( Fig. 2b) , there was a highly significant correlation between the discrepancy in creatinine results and total bilirubin concentration (P<O·OOl). results were obtained (Fig. 3b ). However, using Beckman reagents (Fig. 3c ), the addition of bilirubin to the plasma pool did not affect the results.
(a)
The above samples were then analysed together with icteric patients' plasma omitting the picrate from each of the three reagents. The results are shown in Fig. 4 . When Centrifichem (Fig. 4b ). Using Beckman hydroxide only, no such decrease in absorbance was observed ( Fig. 4c ). Different amounts of bilirubin were then added to a normal human plasma pool which had been dialysed against 0·15 M NliCI to remove all detectable creatinine. The samples were run on the Centrifichem using the three alkaline picrate reagents. Because the samples contained no detectable creatinine, the effect of added bilirubin alone on the change of absorbance could be investigated without having any contribution to colour development from creatinine. Using Centrifichern and J T Baker reagents, a decrease in A520nm was observed in those samples containing added bilirubin with the samples containing the highest concentration showing the largest decrease. When Beckman reagents were used no decrease in A520nm occurred.
In order to ascertain whether the decrease in A 52lJnm observed on reaction of icteric samples with the Centrifichern and J T Baker alkaline picrate reagents was due to the oxidation of bilirubin to biliverdin, the above experiments were repeated using a wavelength of 620 nm instead of 520 nm. At this wavelength, Negative interference by jaundiced pLasma 93 preliminary experiments showed that neither alkaline picrate, alkaline creatinine picrate nor bilirubin had any detectable absorbance, whereas biliverdin had a molar absorbance almost identical to that shown by bilirubin at 520 nm.
When Centrifichem or J T Baker reagents were used, an increase in A620nm was observed, with the largest increases occurring in those samples containing the highest concentrations of bilirubin. No significant change in A620nm was found using Beckman reagents. Plasma creatinine concentrations were determined in triplicate on two normal, two uraemic and four icteric samples using the SMA2 Jaffe method. The samples were then re-analysed in triplicate on the Centrifichem using five different kinetic Jaffe procedures In which the picrate concentration, hydroxide concentration and reaction temperature were varied. Representative results are shown in Table 2 . Increasing the final concentration of picrate In the reaction mixture from 4 to 35 mmol/L, the concentration of hydroxide from 136 to 200 mmol/L and the reaction temperature from 30 to 37°C all produced successive increments in creatinine concentration for the icteric samples until they more closely resembled those obtained on the SMA2. For the non-icteric samples no such trend was observed. Bilirubin interference was least when the kinetic Jaffe procedure was carried out at 37°C with final concentrations of picrate and hydroxide in the reaction mixture of 35 and 200 mrnol/L respectively .
Of the substances which may be present in elevated concentration in jaundiced plasma only bilirubin showed negative interference in kinetic Jaffe methods for creatinine determination. The amount of bilirubin interference observed was dependent on the reagent used, with Beckman reagents showing little interference and Centrifichem and J T Baker reagents marked interference. Interference was directly related to the concentration of bilirubin with increasing interference as the concentration of bilirubin in the sample was increased. This report is the first to demonstrate significant negative interference by conjugated as well as unconjugated bilirubin. In addition, both conjugated and unconjugated bilirubin reduced the precision of the creatinine estimation when Centrifichem and J T Baker reagents were rate of reaction of bilirubin with hydroxide as monitored by the rate of change In A521Jnm' Further increases in hydroxide concentration did not significantly increase the rate of reaction. No difference in the rate of reaction of bilirubin with hydroxide was noted on increasing the temperature from 30°to 37°C. used. It is possible that some of the discrepancies in the literature on bilirubin interference can be related to this effect of bilirubin on the precision of the creatinine analysis. In fact, the highly significant linear relationship between bilirubin concentration and amount of interference using the Centrifichem and J T Baker kinetic methods might have been missed if each sample had not been analysed in replicate.
Our findings have also shown that interference by both conjugated and unconjugated bilirubin is independent of creatinine concentration and that the recovery of added creatinine to plasma is unaffected by the presence of large amounts of bilirubin. This has important implications for the interpretation of plasma creatinine results because it means that a given concentration of bilirubin will tend to produce the same decrease in plasma creatinine regardless of the plasma creatinine concentration in the sample. Thus, samples containing low concentrations of creatinine will appear to be affected to a greater extent in percentage terms than samples containing high concentrations of creatinine. Bilirubin interference will therefore have its greatest effect at diagnostic cut-off limits, namely, the upper limit of the reference range, particularly in paediatric patients.
Treatment of icteric patients' plasma with light to break down the endogenous bilirubin resulted in a large increase in the apparent plasma creatinine concentration when the samples were analysed using Centrifichem or J T Baker reagents. This increase in plasma creatinine concentration following light treatment occurred regardless of whether the bilirubin in the samples was mainly conjugated or unconjugated and did not occur when the samples were analysed on the SMA2 or the Beckman analyser using Beckman reagents.
Because the SMA2 creatinine method did not suffer from bilirubin interference, the difference between results obtained on the Centrifichem using Centrifichem reagents and the SMA2 could be used as a measure of the interference obtained at a particular concentration of bilirubin. The linear relationship between the discrepancy in creatinine results obtained by the two Jaffe methods and bilirubin concentration provides strong evidence that bilirubin is the substance in icteric patients' plasma that is responsible for negative interference in the Centrifichem kinetic Jaffe procedure.
This study supports the view that bilirubin in plasma is oxidised to biliverdin by the hydroxide in the Centrifichem and J T Baker alkaline picrate reagents. Oxidation is dependent on the concentration of bilirubin and causes a decrease in A520nm which tends to oppose the increase in A52lJnm due to the formation of the creatininepicrate complex. The magnitude of the decrease in A52lJnm when icteric samples are mixed with hydroxide is similar to the reduction in the rate of increase in A S20nm observed when the same samples are mixed with alkaline picrate and is therefore sufficient to account for the observed interference. In addition, the oxidation of bilirubin by alkali appears to be independent of the presence of picrate since it occurs when samples containing bilirubin are mixed with hydroxide only. It also appears to be independent of the presence of creatinine since it occurs in samples containing added bilirubin which have been pre-dialysed to remove all the creatinine. Because the oxidation of bilirubin by alkali is independent of the presence of creatinine, bilirubin interference in the Centrifichem and J T Baker kinetic procedures ought to be independent of the creatinine concentration and this is precisely what is observed experimentally. The simultaneous increase in A62lJnm which accompanies the decrease in A520nm on addition of hydroxide or alkaline picrate to icteric plasma supports the view that bilirubin is indeed oxidised to biliverdin during the reaction. Further support for the proposed mechanism of bilirubin interference comes from the studies using the Beckman hydroxide reagent. When icteric plasma is mixed with Beckman hydroxide, the decrease in AS20nm observed using Centrifichem and J T Baker hydroxide does not occur. Neither is there any increase in A620nm corresponding to the formation of biliverdin. The Beckman hydroxide reagent must therefore contain a substance which inhibits the oxidation of bilirubin to biliverdin and this is why bilirubin interference using Beckman reagents is negligible.
The reason why bilirubin adversely affects the precision of plasma creatinine analyses is unclear. It is likely that factors other than hydroxide concentration are important for the oxidation of bilirubin to biliverdin; for example, the presence of dust particles or crystals in the reagent which might act as 'catalytic surfaces' upon which oxidation of bilirubin could occur, or the concentration of dissolved oxygen in reagents.
Previous authors have proposed explanations for the mechanism of bilirubin interference in kinetic Jaffe procedures. Daugherty, Hammond and Osberg" suggested that bilirubin affected the rate of the Jaffe reaction, whereas Watkins et al." showed that bilirubin could be oxidised to biliverdin in alkaline solution with a simultaneous decrease in A,lOnm' This study supports the findings of Watkins et al." There is no evidence that bilirubin actually affects the rate of formation of the creatinine picrate complex. It has been suggested that bilirubin was not primarily the cause of the interference at all but that other unidentified substances present in jaundiced serum samples were responsible.'!' 13 However, the significant correlation between bilirubin concentration and the amount of interference obtained does not support this view and it is likely that the poor correlation between bilirubin concentration and interference obtained by these authors was due to the effect of bilirubin on precision of the creatinine determination.
The reason why Beckman reagents prevent the oxidation of bilirubin to biliverdin is unclear. The reagent contains 150 mmol/L sodium hydroxide buffered with borate/phosphate and a surfactant. The incorporation of borate/ phosphate in the hydroxide reagent was shown to reduce interference from glucose by complexing with the carbohydrate in patients' samples. 19 Addition of surfactant to the reagent has been shown to reduce matrix effects presumably from serum proteins found in certain samples.l?' 20 It is unlikely that the above modifications to the Jaffe reagent would significantly reduce bilirubin interference because both borate/phosphate and surfactant at high concentration are incorporated into the J T Baker reagent, a reagent we have shown to be highly susceptible to bilirubin interference. Furthermore, the suggestion that Beckman reagents prevent bilirubin interference by rapidly oxidising bilirubin to biliverdin is not supported by the data presented in this paper. 9 In contrast, our results suggest that the Beckman reagent works by inhibiting the oxidation of bilirubin to biliverdin.
The rate of formation of the creatinine picrate complex is known to increase with temperature, hydroxide concentration and picrate concentration. 23 An increase in temperature also causes an increase in absorbance of both alkaline picrate and alkaline creatinine picrate.j" As the reaction of bilirubin with hydroxide is unaffected by the presence of picrate and is relatively independent of temperature and hydroxide concentration above 100 mmol/L, increasing the temperature, hydroxide or picrate con-centration in the kinetic Jaffe procedure ought to reduce bilirubin interference. This is because the decrease in A~Qllnm due to the oxidation of bilirubin by hydroxide becomes relatively insignificant compared to the large increase in A,2ol1m due to the formation of the creatinine picrate complex when the kinetic Jaffe procedure is carried out at high temperature in the presence of increased concentrations of hydroxide and picrate. This has been confirmed in the present study and it is clear from our results that bilirubin interference could be almost abolished simply by carrying out the kinetic Jaffe procedure at a temperature of 37°C with final concentrations of picrate and hydroxide of 35 and 200 mmollL respectively. It is therefore interesting to note that out of the 15 sets of assay conditions for kinetic Jaffe methods summarised by Spencer." only four used hydroxide concentrations above 195 mmollL, only one used a picrate concentration greater than 30 mmollL and only four used reaction temperatures of 37°C or more.
The varied findings by different authors on the effect of bilirubin in kinetic Jaffe procedures can be explained by the adverse effect bilirubin has on the precision of the creatinine analysis, the use of a wide range of reagent concentrations and possibly to the incorporation of additional components into the alkaline picrate reagent which modulate the oxidation of bilirubin by hydroxide.
The best Jaffe procedure for the estimation of plasma creatinine in icteric samples was the continuous flow Jaffe procedure. All three kinetic methods showed some bilirubin interference, although for the Beckman reagents this was negligible and would not affect clinical decision-making.
It is not necessary to use alkaline picrate reagents containing additional components to reduce interference from bilirubin in kinetic Jaffe methods. It is recommended that more use is made by laboratories of those kinetic Jaffe reagents which contain high concentrations of hydroxide and picrate. Such reagents would appear to be virtually free from bilirubin interference. The use of kinetic Jaffe reagents containing ferricyanide and SDS in their present formulation is not recommended for the determination of plasma creatinine in icteric samples.
